SMG9
Basic information
Region (hg38): 19:43727983-43754962
Previous symbols: [ "C19orf61" ]
Links
Phenotypes
GenCC
Source:
- heart and brain malformation syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Heart and brain malformation syndrome; Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Neurologic; Ophthalmologic | 27018474; 35087184 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMG9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 17 | ||||
missense | 36 | 39 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 4 | 1 | 6 | ||
non coding | 3 | |||||
Total | 1 | 3 | 37 | 19 | 4 |
Variants in SMG9
This is a list of pathogenic ClinVar variants found in the SMG9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-43731608-G-A | Likely benign (Mar 06, 2018) | |||
19-43731651-C-G | Heart and brain malformation syndrome | Pathogenic (Feb 13, 2024) | ||
19-43731657-C-T | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
19-43732878-C-T | SMG9-related disorder | Likely benign (Jan 29, 2024) | ||
19-43732916-G-A | Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies | Pathogenic (Apr 10, 2024) | ||
19-43732922-G-A | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
19-43732952-G-A | Inborn genetic diseases | Uncertain significance (Apr 08, 2024) | ||
19-43732963-T-C | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
19-43732990-C-T | Inborn genetic diseases | Uncertain significance (Oct 12, 2021) | ||
19-43733373-C-T | Benign/Likely benign (Nov 01, 2024) | |||
19-43733388-C-T | SMG9-related disorder | Likely benign (Jun 26, 2020) | ||
19-43733405-C-G | Inborn genetic diseases | Uncertain significance (Apr 12, 2022) | ||
19-43733414-G-A | Inborn genetic diseases | Uncertain significance (Jan 23, 2017) | ||
19-43733419-G-A | Uncertain significance (Mar 01, 2024) | |||
19-43733428-T-C | Uncertain significance (Jan 24, 2023) | |||
19-43733627-C-T | SMG9-related disorder | Likely benign (May 22, 2023) | ||
19-43733659-G-A | Neurodevelopmental abnormality • Heart and brain malformation syndrome | Pathogenic (Jan 18, 2023) | ||
19-43733682-C-T | Heart and brain malformation syndrome | Benign/Likely benign (Sep 27, 2021) | ||
19-43733692-G-A | Inborn genetic diseases | Uncertain significance (May 14, 2021) | ||
19-43733712-C-T | Inborn genetic diseases | Uncertain significance (Apr 30, 2021) | ||
19-43734380-G-T | SMG9-related disorder | Likely benign (Jan 31, 2020) | ||
19-43734420-G-A | SMG9-related disorder | Likely benign (Oct 28, 2019) | ||
19-43734424-C-A | Inborn genetic diseases | Uncertain significance (May 04, 2021) | ||
19-43734429-T-G | Likely benign (Dec 31, 2019) | |||
19-43734444-G-A | SMG9-related disorder | Benign (Nov 11, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMG9 | protein_coding | protein_coding | ENST00000270066 | 13 | 23842 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.46e-13 | 0.278 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.60 | 240 | 320 | 0.749 | 0.0000189 | 3369 |
Missense in Polyphen | 54 | 84.374 | 0.64001 | 835 | ||
Synonymous | 0.592 | 113 | 121 | 0.932 | 0.00000699 | 1058 |
Loss of Function | 1.13 | 23 | 29.7 | 0.775 | 0.00000164 | 304 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000782 | 0.000656 |
Ashkenazi Jewish | 0.000202 | 0.000198 |
East Asian | 0.000492 | 0.000489 |
Finnish | 0.000187 | 0.000185 |
European (Non-Finnish) | 0.000282 | 0.000281 |
Middle Eastern | 0.000492 | 0.000489 |
South Asian | 0.000263 | 0.000261 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Is recruited by release factors to stalled ribosomes together with SMG1 and SMG8 (forming the SMG1C protein kinase complex) and, in the SMG1C complex, is required for the efficient association between SMG1 and SMG8 (PubMed:19417104). Plays a role in brain, heart, and eye development (By similarity). {ECO:0000250|UniProtKB:Q9DB90, ECO:0000269|PubMed:19417104}.;
- Disease
- DISEASE: Heart and brain malformation syndrome (HBMS) [MIM:616920]: An autosomal recessive syndrome characterized by multiple congenital anomalies such as cardiac defects, brain malformations, including cerebellar vermis hypoplasia, hypoplastic corpus callosum and Dandy-Walker malformation, profoundly delayed psychomotor development, microphthalmia, and facial dysmorphism. {ECO:0000269|PubMed:27018474}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.45
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- Y
- hipred_score
- 0.564
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smg9
- Phenotype
- vision/eye phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;eye development;brain development;heart development
- Cellular component
- cytosol
- Molecular function
- protein binding;identical protein binding